The Healthcare Summit and Expo 2023 will focus on the novel concepts, treatments, strategies, and methods to promote excellence and achieve state of the art healthcare for veterans and others living with spinal cord injuries and diseases and dysfunctions, Multiple Sclerosis and Amyotrophic Lateral Sclerosis.
The mission of Healthcare Summit and Expo 2023 is to bring together professionals across the continuum of care who are treating individuals living with spinal cord injury (SCI) and dysfunction, multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS) to share new clinical information, research data and innovative initiatives to improve care and support clinicians in maintaining their specialty certification and/or license to practice.
To enhance interdisciplinary care across the lifespan of individuals with SCI and diseases;
To assess advances in the delivery of healthcare and promote innovative models of care management;
To improve practice skills of clinicians, surgeons, researchers, and administrators;
To discuss evidence-based medicine;
To expand the body of knowledge about spinal cord injury and diseases and their medical complications and consequences;
To identify cutting edge research priorities
To present data on new developments in assessment, treatment and health policy.
Healthcare Summit + Expo 2023 provides an interdisciplinary opportunity to network with healthcare professionals working across the continuum in spinal cord injury and disease care and treatment. Sessions are geared for healthcare providers including:
Abstracts are intended to represent clinical practice, research or health policy content related to spinal cord injury, multiple sclerosis, ALS or other spinal cord disorders.
All submitted abstracts must meet CME/CEU accreditation standards to be approved for credit. Abstracts of presentations should be balanced and free of commercial bias. Commercial content, product endorsements, or service related advertisements are not permitted. Presentations by speakers with vested or fiduciary interest in product will not be accepted.
Topics should address clinical treatment, research, health policy or program development in the areas of:
Preconference Institute (on Monday, August 14 only)
Bench Research (Scientific Papers)
Presentations may be on research or clinical issues and must be 30 or 75 minutes in length, with an additional 15 minutes allotted for questions and discussion (total 45 or 90 minutes). An additional option this year will include a 15-minute scientific paper to describe the results of a bench research project.
Information on all contributing authors may be included in the abstract submission; however, only the presenters will be listed in the Healthcare Summit + Expo 2023 program.
The abstract should include a summary of information to be presented, including major themes, expanded version of learning objectives, outline of issues/subjects to be discussed, an overview of case studies, points to be illustrated, and principles to be discussed during the interactive session. 90-minute sessions and preconference institutes should include some interactive / audience involvement component.
Clinical Practice/Program Abstracts
A poster is a visually formatted presentation of a topic using charts, graphs, illustrations, and photographs to supplement a written narrative. The topic may be clinically or research based, and describe new techniques, procedures, or technologies. It provides a visual forum for one‐to‐one discussion with the presenter.
Presenters will have the opportunity to discuss pertinent issues highlighted in the poster with attendees during the viewing sessions. Interactive viewing sessions, with presenter present, are scheduled during the Healthcare Summit + Expo. Posters will be available for viewing throughout the meeting.
Clinical Practice/Program Abstracts
Please keep in mind that reference to equipment, devices, or pharmaceutical products must use the correct manufacturer, trade, and/or generic names; appropriate acknowledgements for financial support must be declared. In all cases, patient anonymity must be protected in accordance with the HIPAA Privacy Law. Please do not duplicate your abstract submission for two types of sessions (i.e. poster and platform). Only submit your abstract one time with the preferred session type selected.
The judging criteria for abstract acceptance/non-acceptance is as follows:
The topic is pertinent to the development of knowledge related to SCI/D, MS, ALS clinical practice and is relevant to the purpose and mission of the PVA Summit Symposium.
The abstract enhances the foundation for clinical decision-making or stimulates thinking about practice applications when caring for the SCI/D, MS or ALS patient.
Overall, the abstract is readable, accurately presented and conclusion is valid. The abstract is complete including all data collection. Spelling and grammar are correct.
The presentation demonstrates an insightful application or a creative and original solution to a clinical practice issue or problem caring for the patient with SCI/D, MS, or ALS.
All applicants will be notified of proposal approval / disapproval by Friday, March 24, 2023. If you are unable to accept the session assignment, you must contact PVA by April 7, 2023 at Summit@pva.org.
Should a presenter be unable to make a presentation after acceptance of the assignment, please immediately contact Cheryl Vines at email@example.com or 202-256-5526.
Final PowerPoint slides of your presentation must be submitted, using the online system, on or before June 30, 2023.
PVA will provide the following reimbursement to help defray expenses for accepted session speaker(s):
ONLY SPEAKERS LISTED ON THE ABSTRACT MAY RECEIVE REIMBURSEMENT, SPEAKERS ADDED AFTER ABSTRACT SUBMISSION WILL NOT RECEIVE REIMBURSEMENT
If you have program-related questions, please contact us at Summit@pva.org.
For technical assistance, please contact: AffinityCE technical support at firstname.lastname@example.org.